AMG National Trust Bank’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,187
Closed -$908K 466
2022
Q4
$908K Buy
16,187
+194
+1% +$9.87K 0.03% 288
2022
Q3
$677K Buy
15,993
+301
+2% +$15.4K 0.03% 314
2022
Q2
$848K Sell
15,692
-256
-2% -$15.4K 0.03% 282
2022
Q1
$1.02M Sell
15,948
-292
-2% -$19.2K 0.03% 261
2021
Q4
$1.09M Hold
16,240
0.03% 264
2021
Q3
$1.11M Buy
16,240
+200
+1% +$14.1K 0.04% 258
2021
Q2
$1.09M Buy
16,040
+27
+0.2% +$1.91K 0.03% 261
2021
Q1
$1.11M Buy
16,013
+256
+2% +$17.3K 0.04% 256
2020
Q4
$1.02M Sell
15,757
-548
-3% -$29.5K 0.04% 247
2020
Q3
$770K Sell
16,305
-280
-2% -$13.3K 0.03% 262
2020
Q2
$779K Sell
16,585
-466
-3% -$22.9K 0.03% 255
2020
Q1
$762K Buy
17,051
+2,221
+15% +$117K 0.06% 134
2019
Q4
$864K Buy
14,830
+178
+1% +$10.6K 0.05% 173
2019
Q3
$880K Buy
14,652
+659
+5% +$39.3K 0.05% 160
2019
Q2
$782K Buy
+13,993
New +$721K 0.05% 161

Other funds holding IART

AMG National Trust Bank's IART Position: Q1 2023 in Review

AMG National Trust Bank sold out of Integra LifeSciences (IART) in Q1 2023, closing a stake of 16,187 shares — an estimated $908K sold.

AMG National Trust Bank first reported a position in IART in Q2 2019 and held it in 15 quarters. The position peaked at $1.11M in Q3 2021. 279 funds tracked by Wall St. Rank hold IART as of Q1 2023.

  • AMG National Trust Bank reported no remaining Integra LifeSciences position as of Q1 2023 after selling out during the quarter.
  • AMG National Trust Bank sold 16,187 Integra LifeSciences shares in Q1 2023, an estimated $908K.
  • AMG National Trust Bank first reported a position in Integra LifeSciences in Q2 2019 and held it in 15 quarters.
  • AMG National Trust Bank's Integra LifeSciences position peaked at $1.11M in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2023.

Based on AMG National Trust Bank's 13F filing for Q1 2023, filed 10 May 2023.